FDA Investigator Foley
Foley has inspections in 1 countries as of 18 Aug 2023. Foley has collaborated with a combined 1738 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
29
Last Inspection Date:
18 Aug 2023
Investigator Role:
FDA Investigator (Contractor)
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alex G Kalugin,
Alice A Blair,
Amanda N Schaupp,
Andrew B Slarve,
Andrew Betz,
Andrew E Kay,
Andrew T Todd,
Andrew Tadros,
Angel K Sandhu,
Baker,
Blair,
Brian R Henderson,
Bruce D Broidy,
Capri R Woolridge,
Carr,
Christine M Parmentier,
Cindy W Lewis,
Courtney R Bolton,
Cynthia L Ford,
Damon A Growl,
Daniel C Geffin,
Daniel J Roberts,
Daniel Velasquez,
Darla R Bracy,
David A Lum,
David A Quale,
Debra D Devlieger,
Denise Connelly,
Edna J Hidalgo,
Elizabeth S Furukawa,
Elodie Xtong Lin,
Elsa Y Yu,
Emal Wahab,
Emily Chang,
Emmanuel O Kerry,
Eric J Ferguson,
Erica R Pomeroy,
Gillenwater,
Greg K Keshishyan,
Italia Nappi,
James C Lee, PharmD,
Janice R Small,
Janice Wai,
Jeanne A Young,
Jeanne M Weishaar,
Jennifer Crumb,
Jennifer S King,
Jessica J Lee,
Jessica M Monteiro,
Jocelyn T Ramos,
John A Liu,
Jolene S Hedgecock,
Joseph M Willems,
Joseph Tibay,
Juan A Morales,
Juliane Kjung Lau,
Kacie M Crowther,
Karen D Phung,
Karla J Gibler,
Katie T Duong,
Kawshalya Pathiraja,
Kevin P Foley,
Kin T Moy,
Larkin R Buckalew,
Lawton W Lum,
Lealand Lee,
Leongc,
Linda J Cruz,
Linda Linh T Nguyen,
Linda S Shook,
Lorraine N Williams,
Lucila B Nwatu,
Luis A Solorzano,
Lydia S Chan,
Macropolk,
Maida Henesian (NMI),
Maridali De Leon Torres,
Marissa J Chan,
Mark I Nakano,
Mcgrewp,
Megan E Kulas,
Melody M Ragasa Leong,
Nancy E Doyle,
Nicole Yuen,
Nympha V Florendo,
Paula E Davis Debella,
Phung,
Quynh H Strandberg,
Randall J Plunkett,
Randall P Zielinski,
Rashonda N Rucker,
Roberta K Smith,
Roger D Gawne,
Ronald P Boyce,
Sandra S Saniga,
Sara M Richardson,
Sergio Chavez (NMI),
State Agency,
Steven J Branch,
Steven M Galvez,
Thomas N Adjabeng,
Tiffany Chao,
Timothy C Grome,
Victoria Taylor,
Warren E Savary,
Wayne L Jefferson,
Wendy S Shenk
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more